1. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis ?;Dyerberg, J.; Bang, H.O.; Stofferson, E.; Moncada, S.; Vane, JR;Lancet,1978
2. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication;Dormandy, J.A.; Hoare, E.; Colley, J.; Arrowsmith, D.E.; Dormandy, T.L.;Br MedJr,1973
3. Reduction in blood viscosity by eicosapentaenoic acid;Kobayashi, S.; Hirai, A.; Terano, T.; Hamazaki, T.; Tamura, Y.; Kumagai, A.;Lancet,1981
4. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication;Dormandy, J.A.; Hoare, E.; Khattab, A.H.; Arrowsmith, D.E.; Dormandy, T.L.,1973
5. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity, red cell deformability in healthy human subjects;Terano, T.; Hirai, A.; Hamazaki, T.;Atherosclerosis,1983